| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| aripiprazole 400 mg + inert substance modified release injection, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 128 mg/0.36 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 96 mg/0.27 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Monthly 128 mg/0.36 mL modified release injection, 0.36 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 64 mg/0.18 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Monthly 96 mg/0.27 mL modified release injection, 0.27 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 32 mg/0.64 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Weekly 32 mg/0.64 mL modified release injection, 0.64 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Monthly 64 mg/0.18 mL modified release injection, 0.18 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 24 mg/0.48 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Weekly 8 mg/0.16 mL modified release injection, 0.16 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 8 mg/0.16 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Weekly 24 mg/0.48 mL modified release injection, 0.48 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Weekly 16 mg/0.32 mL modified release injection, 0.32 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 16 mg/0.32 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| exenatide 2 mg/0.85 mL modified release injection, 2 mL pen device |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| aripiprazole 400 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Abilify Maintena (aripiprazole 400 mg) modified release injection, 400 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| exenatide 2 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Sublocade 300 mg/1.5 mL modified release injection, 1.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 100 mg/0.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Sublocade 100 mg/0.5 mL modified release injection, 0.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 300 mg/1.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot Paediatric (leuprorelin acetate 30 mg) modified release injection, 30 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 22.5 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 45 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 6-Month (leuprorelin acetate 45 mg) modified release injection, 45 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 7.5 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 30 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 4-Month (leuprorelin acetate 30 mg) modified release injection, 30 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| methylprednisolone acetate 40 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Depo-Medrol 40 mg/mL modified release injection, 1 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Depo-Nisolone 40 mg/mL modified release injection, 1 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Cabenuva Rilpivirine 900 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| cabotegravir 600 mg/3 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| rilpivirine 600 mg/2 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| cabotegravir 400 mg/2 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| rilpivirine 900 mg/3 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Cabenuva Rilpivirine 600 mg/2 mL modified release injection, 2 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| buprenorphine 160 mg/0.45 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Buvidal Monthly 160 mg/0.45 mL modified release injection, 0.45 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine (as pamoate) 300 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine (as pamoate) 300 mg) modified release injection, 300 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine (as pamoate) 210 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine (as pamoate) 405 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine (as pamoate) 210 mg) modified release injection, 210 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Zyprexa Relprevv (olanzapine (as pamoate) 405 mg) modified release injection, 405 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide (as embonate) 20 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide (as embonate) 40 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide (as embonate) 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide (as embonate) 40 mg) modified release injection, 40 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| pasireotide (as embonate) 60 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Signifor LAR (pasireotide (as embonate) 60 mg) modified release injection, 60 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Octreotide Depot (Teva) (octreotide 10 mg) modified release injection, 10 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Octreotide Depot (Teva) (octreotide 30 mg) modified release injection, 30 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Octreotide Depot (Teva) (octreotide 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Hafyera 700 mg/3.5 mL modified release injection, 3.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 1 g/5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Hafyera 1 g/5 mL modified release injection, 5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 700 mg/3.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Apretude 600 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Sustenna 150 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 100 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 25 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 50 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 75 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| paliperidone 150 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 7.5 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine 405 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| octreotide 30 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| risperidone 25 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| lanreotide 30 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 30 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 22.5 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine 210 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| risperidone 37.5 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| leuprorelin acetate 45 mg injection: modified release, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| olanzapine 300 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| octreotide 10 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| risperidone 50 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Risperdal Consta (risperidone 25 mg) modified release injection, 25 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| morphine sulfate pentahydrate 10 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Eligard 6 Month (leuprorelin acetate 45 mg) injection: modified release, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Risperdal Consta (risperidone 37.5 mg) modified release injection, 37.5 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Depodur 10 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Synacthen Depot 1 mg/mL modified release injection, ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| tetracosactide 1 mg/mL modified release injection, ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Lucrin Depot 4-Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
| Invega Sustenna 100 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Sandostatin LAR (octreotide 10 mg) modified release injection, 10 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Sustenna 50 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
| Invega Sustenna 25 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|